作者: H A Sackeim
DOI:
关键词: Pharmacotherapy 、 Antidepressant 、 Depression (differential diagnoses) 、 Combined Modality Therapy 、 Early Relapse 、 Continuation 、 Electroconvulsive therapy 、 Intensive care medicine 、 Medicine 、 Somatic psychology
摘要: The use of electroconvulsive therapy (ECT) in major depression typically involves sequential treatment trials. Most patients fail one or more antidepressant medications before receiving ECT, and who respond to ECT usually receive continuation pharmacotherapy. Indeed, is the only somatic psychiatry that discontinued when it found be effective. This paper reviews relations medication resistance during acute episode short-term response pharmacotherapy as methods prevent relapse. Recent research contradicts long-held view failure adequate trials anti-depressant has no impact on ECT. Further, recent documented high relapse rates following questioned efficacy using traditional for pharmacotheraphy have established those same agents episode. Continuation strong potential a method early relapse, but its never been demonstrated controlled research. In each these areas, detailed recommendations are given future